antirotaviral (Taiyo/Fujimoto/Riken)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Nameantirotaviral (Taiyo/Fujimoto/Riken)
Drug Alias Namesialylphospholipid (Taiyo/Fujimoto/Riken)SPL (Taiyo/Fujimoto/Riken)SPL
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRotavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTaiyo Kagaku KK
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRiken Chemical Industry Co LtdTaiyo Kagaku KKFujimoto Pharmaceutical Corp
Active IndicationsN/A
Inactive IndicationsRotavirus Infections

Other Information

ATC CodeN/A
Related LinksN/A